{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:27:14Z","timestamp":1794274034184,"version":"4.9.0"},"reference-count":37,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES:<\/jats:title>\n                  <jats:p>We examined overall and incremental effectiveness of 2-dose varicella vaccination in preventing community transmission of varicella among children aged 4 to 18 years in 2 active surveillance sites. One-dose varicella vaccine effectiveness (VE) was examined in those aged 1 to 18 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>From May 2009 through June 2011, varicella cases identified during active surveillance in Antelope Valley, CA and Philadelphia, PA were enrolled into a matched case\u2013control study. Matched controls within 2 years of the patient\u2019s age were selected from immunization registries. A standardized questionnaire was administered to participants\u2019 parents, and varicella vaccination history was obtained from health care provider, immunization registry, or parent records. We used conditional logistic regression to estimate varicella VE against clinically diagnosed and laboratory-confirmed varicella.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>A total of 125 clinically diagnosed varicella cases and 408 matched controls were enrolled. Twenty-nine cases were laboratory confirmed. One-dose VE (1-dose versus unvaccinated) was 75.6% (95% confidence interval [CI], 38.7%\u201390.3%) in preventing any clinically diagnosed varicella and 78.1% (95% CI, 12.7%\u201394.5%) against moderate or severe, clinically diagnosed disease (\u226550 lesions). Among subjects aged \u22654 years, 2-dose VE (2-dose versus unvaccinated) was 93.6% (95% CI, 75.6%\u201398.3%) against any varicella and 97.9% (95% CI, 83.0%\u201399.7%) against moderate or severe varicella. Incremental effectiveness (2-dose versus 1-dose) was 87.5% against clinically diagnosed varicella and 97.3% against laboratory-confirmed varicella.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>Two-dose varicella vaccination offered better protection against varicella from community transmission among school-aged children compared with 1-dose vaccination.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2015-2802","type":"journal-article","created":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T12:46:17Z","timestamp":1457959577000},"source":"Crossref","is-referenced-by-count":31,"title":["Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era"],"prefix":"10.1542","volume":"137","author":[{"given":"Dana","family":"Perella","sequence":"first","affiliation":[{"name":"Philadelphia Department of Public Health, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbin","family":"Wang","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Civen","sequence":"additional","affiliation":[{"name":"Los Angeles County Department of Public Health, Los Angeles, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra","family":"Viner","sequence":"additional","affiliation":[{"name":"Philadelphia Department of Public Health, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Kuguru","sequence":"additional","affiliation":[{"name":"Los Angeles County Department of Public Health, Los Angeles, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irini","family":"Daskalaki","sequence":"additional","affiliation":[{"name":"Philadelphia Department of Public Health, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Scott","family":"Schmid","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana S.","family":"Lopez","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung Fu","family":"Tseng","sequence":"additional","affiliation":[{"name":"Southern California Permanente Medical Group, Kaiser Permanente, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Claire","family":"Newbern","sequence":"additional","affiliation":[{"name":"Philadelphia Department of Public Health, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurene","family":"Mascola","sequence":"additional","affiliation":[{"name":"Los Angeles County Department of Public Health, Los Angeles, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie R.","family":"Bialek","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"2021120921370763200_B1","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/522150","article-title":"Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997\u20132005.","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis"},{"key":"2021120921370763200_B2","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites: United States, 1995\u20132005.","volume":"197","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"issue":"2","key":"2021120921370763200_B3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1542\/peds.2010-0962","article-title":"Varicella-related hospitalizations in the United States, 2000\u20132006: the 1-dose varicella vaccination era.","volume":"127","author":"Lopez","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"2021120921370763200_B4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1542\/peds.2010-3385","article-title":"Near elimination of varicella deaths in the US after implementation of the vaccination program.","volume":"128","author":"Marin","year":"2011","journal-title":"Pediatrics"},{"issue":"18","key":"2021120921370763200_B5","first-page":"389","article-title":"Outbreak of varicella among vaccinated children: Michigan, 2003.","volume":"53","author":"Centers for Disease Control and Prevention (CDC)","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"27","key":"2021120921370763200_B6","first-page":"749","article-title":"Varicella outbreak among vaccinated children: Nebraska, 2004.","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"2021120921370763200_B7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2005-2085","article-title":"One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?","volume":"117","author":"Lopez","year":"2006","journal-title":"Pediatrics"},{"issue":"8","key":"2021120921370763200_B8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/INF.0b013e3181d9f657","article-title":"Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in Philadelphia, Pennsylvania, 2006.","volume":"29","author":"Nguyen","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"2021120921370763200_B9","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1086\/522134","article-title":"Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement: Maine, 2006.","volume":"197","author":"Parker","year":"2008","journal-title":"J Infect Dis"},{"issue":"3 pt 1","key":"2021120921370763200_B10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1542\/peds.113.3.455","article-title":"Chickenpox outbreak in a highly vaccinated school population.","volume":"113","author":"Tugwell","year":"2004","journal-title":"Pediatrics"},{"key":"2021120921370763200_B11","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1086\/522144","article-title":"Varicella outbreak epidemiology in an active surveillance site, 1995\u20132005.","volume":"197","author":"Civen","year":"2008","journal-title":"J Infect Dis"},{"issue":"2","key":"2021120921370763200_B12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine.","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"2021120921370763200_B13","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"32","key":"2021120921370763200_B14","first-page":"609","article-title":"Evolution of varicella surveillance: selected states, 2000\u20132010.","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"2021120921370763200_B15","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-0863","article-title":"Impact of a routine two-dose varicella vaccination program on varicella epidemiology.","volume":"132","author":"Bialek","year":"2013","journal-title":"Pediatrics"},{"issue":"9","key":"2021120921370763200_B16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/INF.0b013e318293308e","article-title":"Decrease in varicella incidence after implementation of the 2-dose recommendation for varicella vaccine in New Hampshire.","volume":"32","author":"Daly","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2021120921370763200_B17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/infdis\/jiq081","article-title":"Impact of 2-dose vaccination on varicella epidemiology: Connecticut\u20142005\u20132008.","volume":"203","author":"Kattan","year":"2011","journal-title":"J Infect Dis"},{"issue":"11","key":"2021120921370763200_B18","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/INF.0000000000000444","article-title":"Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students.","volume":"33","author":"Thomas","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"2021120921370763200_B19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/oxfordjournals.epirev.a017931","article-title":"Epidemiologic methods in immunization programs.","volume":"18","author":"Chen","year":"1996","journal-title":"Epidemiol Rev"},{"issue":"3","key":"2021120921370763200_B20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/jiq052","article-title":"Effectiveness of 2 doses of varicella vaccine in children.","volume":"203","author":"Shapiro","year":"2011","journal-title":"J Infect Dis"},{"issue":"April","key":"2021120921370763200_B21","first-page":"26","article-title":"Population Estimates: Walter R. McDonald & Associates, Inc. (WRMA) for Urban Research","volume":"2010","year":"2009","journal-title":"Los Angeles County ISD"},{"key":"2021120921370763200_B22","volume-title":"2010 Population Estimates","year":"2010"},{"issue":"5","key":"2021120921370763200_B23","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000.","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"issue":"10","key":"2021120921370763200_B24","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1086\/656773","article-title":"Evaluation of laboratory methods for diagnosis of varicella.","volume":"202","author":"Leung","year":"2010","journal-title":"J Infect Dis"},{"issue":"11","key":"2021120921370763200_B25","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jclinepi.2007.02.009","article-title":"Methodological issues in design and analysis of a matched case\u2013control study of a vaccine\u2019s effectiveness.","volume":"60","author":"Niccolai","year":"2007","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2021120921370763200_B26","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1128\/JCM.38.12.4315-4319.2000","article-title":"Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes.","volume":"38","author":"Loparev","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"9","key":"2021120921370763200_B27","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1128\/JCM.38.9.3156-3160.2000","article-title":"Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR.","volume":"38","author":"Loparev","year":"2000","journal-title":"J Clin Microbiol"},{"key":"2021120921370763200_B28","unstructured":"Estimated vaccination coverage with 1+ varicella among children 19\u201335 months of age by state and immunization action plan area. National Immunization Survey. Available at: www.cdc.gov\/vaccines\/imz-managers\/coverage\/nis\/child\/index.html. Accessed September 30, 2014"},{"issue":"11","key":"2021120921370763200_B29","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/infdis\/jit405","article-title":"Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005\u20132009.","volume":"208","author":"Weinmann","year":"2013","journal-title":"J Infect Dis"},{"issue":"8","key":"2021120921370763200_B30","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/INF.0b013e31819c1041","article-title":"An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients: Arkansas, 2006.","volume":"28","author":"Gould","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2021120921370763200_B31","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2012-3303","article-title":"Long-term effectiveness of varicella vaccine: a 14-year, prospective cohort study.","volume":"131","author":"Baxter","year":"2013","journal-title":"Pediatrics"},{"key":"2021120921370763200_B32","article-title":"Vaccine efficacy estimates during institutional-based outbreaks, Indiana 2010.","volume-title":"45th National Immunization Conference","author":"Hazen","year":"2011"},{"issue":"1","key":"2021120921370763200_B33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1542\/peds.2013-4251","article-title":"Impact of vaccination on the epidemiology of varicella: 1995\u20132009.","volume":"134","author":"Baxter","year":"2014","journal-title":"Pediatrics"},{"issue":"1","key":"2021120921370763200_B34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1542\/peds.91.1.17","article-title":"Modified chickenpox in children immunized with the Oka\/Merck varicella vaccine.","volume":"91","author":"Watson","year":"1993","journal-title":"Pediatrics"},{"key":"2021120921370763200_B35","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1086\/522148","article-title":"Laboratory diagnosis and characteristics of breakthrough varicella in children.","volume":"197","author":"Weinmann","year":"2008","journal-title":"J Infect Dis"},{"issue":"48","key":"2021120921370763200_B36","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1016\/j.vaccine.2012.07.076","article-title":"Challenges in confirming a varicella outbreak in the two-dose vaccine era.","volume":"30","author":"Mahamud","year":"2012","journal-title":"Vaccine"},{"issue":"8","key":"2021120921370763200_B37","first-page":"174","article-title":"Two-dose varicella vaccination coverage among children aged 7 years: six sentinel sites, United States, 2006\u20132012.","volume":"63","author":"Lopez","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2015-2802\/1095100\/peds_20152802.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2015-2802\/1095100\/peds_20152802.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T06:15:13Z","timestamp":1639116913000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/137\/4\/e20152802\/81493\/Varicella-Vaccine-Effectiveness-in-Preventing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,1]]},"published-print":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2015-2802","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]},"article-number":"e20152802"}}